Engineered nanomaterials for synergistic photo-immunotherapy

Area of Science:

• Biomedical Engineering
• Cancer Therapy
• Immunology

Background:

• Photodynamic therapy (PDT) and photothermal therapy (PTT) are effective non-invasive cancer treatments but often fail to eradicate tumors completely due to metastasis and recurrence.
• Photo-immunotherapy is emerging as a promising strategy, leveraging phototherapy to trigger immunogenic cell death (ICD) and release tumor-specific antigens (TSAs) and damage-associated molecular patterns (DAMPs).

Purpose of the Study:

• To review the latest strategies for engineering nanomaterials to enhance synergistic photo-immunotherapy against cancer.
• To focus on how nanomaterials can activate anti-tumor immune responses, reverse the tumor immunosuppressive microenvironment (TIME), and improve the efficiency of ICD.

Main Methods:

• Review of current literature on nanomaterial-based synergistic photo-immunotherapy.
• Analysis of strategies involving nanomaterial drug delivery systems for combined phototherapy and immunotherapy.
• Emphasis on mechanisms modulating immune cell interactions and anti-tumor immunity.

Main Results:

• Nanomaterials are crucial for developing effective drug delivery systems for combined photo-immunotherapy.
• Engineered nanomaterials can promote dendritic cell (DC) maturation and cytotoxic T lymphocyte (CTL) infiltration.
• Strategies focus on activating anti-tumor immunity, reversing TIME, and enhancing ICD for improved cancer treatment efficacy.

Conclusions:

• Engineering nanomaterials is key to maximizing the anti-cancer potential of synergistic photo-immunotherapy.
• Addressing challenges in nanomaterial design and understanding immune modulation are crucial for future opportunities in this field.